newsfilter.io

KPRXKIORA PHARMACEUTICALS INC

  1. PR Newswire

    Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders

    Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and Global Genes today announced that Kiora has joined Global Genes' RARE-X Vision Consortium, a... ...

  2. SEC

    EFFECT Form - Notice of Effectiveness - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

    Notice of Effectiveness ...

  3. SEC

    S-3 Form - Registration statement under Securities Act of 1933 - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

    Registration statement under Securities Act of 1933 ...

  4. Analyst Upgrades

    HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target

    HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals with a Buy and maintains $10 price target. ...

  5. SEC

    8-K Form - Current report, items 2.02 and 9.01 - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

    Current report, items 2.02 and 9.01 ...

  6. SEC

    10-Q Form - Quarterly report [Sections 13 or 15(d)] - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

    Quarterly report [Sections 13 or 15(d)] ...

  7. BusinessWire

    Vicarious Surgical Announces Leadership Transition: Stephen From, Healthcare Industry Veteran, Appointed Chief Executive Officer

    Adam Sachs, Co-Founder, to Remain on as President Vicarious Surgical Inc. (NYSE:RBOT, RBOT WS)) (the "Company"), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, ...

  8. SEC

    8-K Form - Current report, items 5.07 and 9.01 - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

    Current report, items 5.07 and 9.01 ...

  9. SEC

    8-K Form - Current report, items 1.01, 7.01, and 9.01 - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

    Current report, items 1.01, 7.01, and 9.01 ...

  10. SEC

    8-K Form - Current report, items 2.02 and 9.01 - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

    Current report, items 2.02 and 9.01 ...

  11. SEC

    10-Q Form - Quarterly report [Sections 13 or 15(d)] - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

    Quarterly report [Sections 13 or 15(d)] ...

  12. SEC

    DEF 14A Form - Other definitive proxy statements - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

    Other definitive proxy statements ...

  13. SEC

    4 Form - Statement of changes in beneficial ownership of securities - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    Statement of changes in beneficial ownership of securities ...

  14. SEC

    4 Form - Statement of changes in beneficial ownership of securities - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    Statement of changes in beneficial ownership of securities ...

  15. SEC

    4 Form - Statement of changes in beneficial ownership of securities - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    Statement of changes in beneficial ownership of securities ...

  16. SEC

    4 Form - Statement of changes in beneficial ownership of securities - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    Statement of changes in beneficial ownership of securities ...

  17. SEC

    4 Form - Statement of changes in beneficial ownership of securities - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    Statement of changes in beneficial ownership of securities ...

  18. SEC

    4 Form - Statement of changes in beneficial ownership of securities - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    Statement of changes in beneficial ownership of securities ...

  19. SEC

    4 Form - Statement of changes in beneficial ownership of securities - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    Statement of changes in beneficial ownership of securities ...

  20. SEC

    4 Form - Statement of changes in beneficial ownership of securities - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    Statement of changes in beneficial ownership of securities ...

  21. SEC

    4 Form - Statement of changes in beneficial ownership of securities - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    Statement of changes in beneficial ownership of securities ...

  22. Analyst Upgrades

    HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target

    HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals with a Buy and maintains $10 price target. ...

  23. SEC

    8-K Form - Current report, items 2.02 and 9.01 - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

    Current report, items 2.02 and 9.01 ...

  24. SEC

    S-8 Form - Securities to be offered to employees in employee benefit plans - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

    Securities to be offered to employees in employee benefit plans ...

  25. SEC

    10-K Form - Annual report [Section 13 and 15(d), not S-K Item 405] - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

    Annual report [Section 13 and 15(d), not S-K Item 405] ...